Home direct-to-consumer telehealth solutions for children with mental health disorders and the impact of Covid-19. (January 2022)

• Record Type: Journal Article
• Authors: Norman, Sierra; Atabaki, Shireen; Atmore, Kathleen; Biddle, Cara; DiFazio, Marc; Felten, Daniel; Fox, Eduardo; Marschall, Donna; Newman, Julie; Robb, Adelaide; Rowland, Cecilia; Selekman, Rachel; Slovin, Ariella; Stein, Mark; Strang, John; Sable, Craig
• Is Part Of: Clinical child psychology and psychiatry. Volume 27:Number 1(2022)
• Page Start: 244
• Page End: 258
• Publication Date: 2022-01
• Subjects: Telehealth -- mental health -- Covid-19 -- children -- psychiatry; Clinical child psychology -- Periodicals; Child psychiatry -- Periodicals; 618.9289
• DOI: 10.1177/13591045211064134
• Languages: English
• ISSNs: 1359-1045

Abstract

Delivery of mental health treatment in the home can close gaps in care. Telehealth also provides access to healthcare that has been disrupted due to the COVID-19 pandemic. In 2016, a home direct-to-consumer telehealth program was initiated. Mental health encounters made up a significant portion of all telehealth encounters and COVID-19 had a significant impact on accelerating the utilization of telehealth. Telemental health has been more successful at meeting targeted volumes than the overall health system. Of all the mental health diagnoses before and during COVID-19, attention deficit hyperactivity disorder, Autism Spectrum Disorder, and Anxiety Disorder were most common. The direct-to-consumer telehealth program saved patients a significant amount of travel miles and associated time, based on data from the period before COVID-19. Payment reimbursement for direct-to-consumer telehealth professional services was similar to reimbursement for in-person visits. This program demonstrates direct-to-consumer telehealth is a feasible and acceptable care modality for a variety of youth mental health disorders.